Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
The article highlights how automation in hospitals may worsen staffing shortages and discourage prospective medical students, creating a long-term burden ...
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...